Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499915 · ClinicalTrials.gov registry record · NA
NICU Asthma Education and Secondhand Smoke Reduction Study
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 165
- Enrollment target
NCT00499915: Completed NA study, sponsored by University of Rochester.
NCT00499915 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 165 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00499915, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
Study Summary
Premature infants have a significantly increased risk for developing respiratory illnesses and asthma. Secondhand smoke (SHS) also is clearly associated with increased breathing problems in children, thus exposure to smoke makes it substantially more likely for a premature infant to develop wheezing. The overall goal of this study is to test whether comprehensive asthma education combined with a home-based secondhand smoke reduction program can reduce exposure to smoke and prevent respiratory illness among premature infants. Our hypotheses are: * More premature infants whose families receive asthma education combined with a SHS reduction intervention will live in smoke-free environments compared to infants receiving only asthma education (control group). * Caregivers receiving the SHS reduction program will have higher rates of quit attempts and less relapse into smoking compared to caregivers in the control group. * Infants whose families receive the combined intervention will experience less respiratory illness compared to infants in the control group.
Primary Outcome
Infants living in homes with a "home smoking ban" rule
Interventions
- BEHAVIORAL Asthma Education
- BEHAVIORAL Secondhand Smoke Reduction and Smoking Cessation Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2007-02 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT00499915 record still lists
NCT00499915 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Asthma Education is the first listed.
NCT00499915 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00499915 about?
NCT00499915 is a clinical study titled "NICU Asthma Education and Secondhand Smoke Reduction Study". Premature infants have a significantly increased risk for developing respiratory illnesses and asthma. Secondhand smoke (SHS) also is clearly associated with increased breathing problems in children, thus exposure to smoke makes it substantially more likely for a premature infant to develop wheezing...
What is the current status of trial NCT00499915?
This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2007-02. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00499915?
The interventions under investigation include: Asthma Education (BEHAVIORAL), Secondhand Smoke Reduction and Smoking Cessation Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00499915?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00499915's enrollment target sits among peer trials
165 626th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia